We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 217 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 2223 (-219)

99.54% less ownership

Funds ownership: 99.59%0.05% (-100%)

100% less capital invested

Capital invested by funds: $3.53B → $2.16M (-$3.52B)

100% less funds holding in top 10

Funds holding in top 10: 180 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 217

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-219
Holders Change %
-98.65%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
2
Closed
217
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TS
76
Twin Securities
New York
-$4.76M -101,402 Closed
First Trust Advisors
77
First Trust Advisors
Illinois
-$4.56M -97,078 Closed
WAM
78
Wolverine Asset Management
Illinois
-$4.55M -96,924 Closed
AQR Capital Management
79
AQR Capital Management
Connecticut
-$4.51M -96,027 Closed
BHMP
80
Bardin Hill Management Partners
New York
-$4.22M -89,853 Closed
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
-$3.59M -76,294 Closed
WAM
82
Weiss Asset Management
Massachusetts
-$3.57M -75,969 Closed
Legal & General Group
83
Legal & General Group
United Kingdom
-$3.54M -75,391 Closed
Citadel Advisors
84
Citadel Advisors
Florida
-$3.5M -74,505 Closed
TCM
85
Tang Capital Management
California
-$3.49M -74,265 Closed
Jane Street
86
Jane Street
New York
-$3.33M -70,814 Closed
T. Rowe Price Associates
87
T. Rowe Price Associates
Maryland
-$3.25M -69,269 Closed
VOYA Investment Management
88
VOYA Investment Management
Georgia
-$3.14M -66,880 Closed
AGP
89
Artia Global Partners
Florida
-$3M -63,930 Closed
Toronto Dominion Bank
90
Toronto Dominion Bank
Ontario, Canada
-$2.72M -57,903 Closed
California State Teachers Retirement System (CalSTRS)
91
California State Teachers Retirement System (CalSTRS)
California
-$2.62M -55,749 Closed
OAC
92
OMERS Administration Corp
Ontario, Canada
-$2.5M -53,300 Closed
PAS
93
Point72 Asia (Singapore)
Singapore
-$2.49M -53,081 Closed
YCM
94
Yakira Capital Management
Connecticut
-$2.45M -52,094 Closed
Qube Research & Technologies (QRT)
95
Qube Research & Technologies (QRT)
United Kingdom
-$2.42M -51,529 Closed
AC
96
Athos Capital
Hong Kong
-$2.35M -50,000 Closed
COPPSERS
97
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$2.35M -50,000 Closed
M
98
Murchinson
Ontario, Canada
-$2.35M -50,000 Closed
HIM
99
HGC Investment Management
Ontario, Canada
-$2.28M -48,443 Closed
IIM
100
INTECH Investment Management
Florida
-$2.27M -48,298 Closed

SWTX Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.53B a quarter earlier.

Sellers outnumbered buyers: 217 funds closed out of SWTX and 0 opened new positions — a net loss of 217 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $341M sold.

  • 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 222 in Q2 2025.
  • Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 217 closed out, a net change of -217 holders.
  • The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.

Based on aggregated 13F filings for Q3 2025.